Atriva Therapeutics

Biotechnology Research • Planegg, Bavaria, Germany • 1-10 Employees

Company overview

Headquarters	Am Klopferspitz 19, Planegg/Martinsried, Bavaria 82152, DE
Phone number	+4969999916210
Website	atriva-therapeutics.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Science, Innovation, Influenza, Respiratory Infection, Antivirals, Mek Inhibitors, Viral Infection
Founded	2015
Employees	1-10
Socials

Key Contact at Atriva Therapeutics

Yvonne Full

Director Preclinical Research

Atriva Therapeutics Email Formats

Atriva Therapeutics uses 1 email format. The most common is {last name} (e.g., doe@atriva-therapeutics.com), used 100% of the time.

Format	Example	Percentage
{last name}	doe@atriva-therapeutics.com	100%

About Atriva Therapeutics

Atriva Therapeutics’ mission is to develop an antiviral therapy platform against severe respiratory and systemic diseases with a high unmet medical need induced by RNA viruses, e.g., influenza and COVID-19. The clinical-stage biopharmaceutical company is pioneering the development of host-targeting antiviral therapies, making development of viral resistance unlikely, and thereby significantly contributing to pandemic preparedness. The Atriva lead product zapnometinib (ATR-002) is a first-in-class, host-targeting agent that aims to inhibit viral replication and to favorably modulate the body’s immune response to RNA viruses. Atriva Therapeutics was founded in 2015 in Tübingen by a team of leading scientists in viral research and seasoned industry experts and is based in Tübingen, Frankfurt, and Martinsried (IZB, near Munich), Germany. Atriva is a founding member of the BEAT-COV initiative. www.beat-cov.de For further information, please visit www.atriva-therapeutics.com and follow us on LinkedIn and Twitter (@AtrivaTx).

Atriva Therapeutics revenue & valuation

Annual revenue	$3,500,000
Revenue per employee	$350,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,200,000
Total funding	$10,100,000

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Vice President

Director

Employees by Department

Atriva Therapeutics has 4 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Atriva Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-09-12	12	$10,100,000

Funding Insights

$10,100,000

Total funding amount

$10,100,000

Most recent funding amount

Number of funding rounds

Atriva Therapeutics Tech Stack

Discover the technologies and tools that power Atriva Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Swiper

JavaScript libraries

jQuery Migrate

JavaScript libraries

Neve

WordPress themes

jQuery

JavaScript libraries

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Gutenberg

Editors

GoDaddy CoBlocks

Page builders

Nginx

Reverse proxies

Lightbox

JavaScript libraries

WPMU DEV Smush

WordPress plugins

Frequently asked questions

Atriva Therapeutics is located in Planegg, Bavaria, DE.

You can reach Atriva Therapeutics at +4969999916210.

Atriva Therapeutics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

Atriva Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Atriva Therapeutics has raised a total of $10,100,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Atriva Therapeutics

Yvonne Full

Director Preclinical Research

4.8

40,000 users